Finepoint Capital »

Travere Therapeutics shares owned by Finepoint Capital

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Finepoint Capital from 13F filings

Historical chart of Finepoint Capital investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Finepoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Finepoint Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.0M 896k 8.94
2023-06-30 $12M 762k 15.36
2023-03-31 $20M 875k 22.49
2022-12-31 $22M 1.0M 21.03
2022-09-30 $25M 1.0M 24.64
2022-06-30 $14M 584k 24.23